Source: China – South China Morning PostChina is on track to approve its first drug for Covid-19, possibly within weeks.
This comes as Chinese scientists race to find effective treatment for the disease, crucial for the country with a zero-tolerance strategy before it can consider reopening its borders, even as vaccination remains a priority.
Conditional approval may be given to a neutralising monoclonal antibody treatment co-developed by Chinese and US researchers by the end of the year, according to an official publication of the…Read More